Integrated Diagnostics Holdings Stock Fundamentals
| IDHC Stock | 0.40 0.02 5.26% |
Integrated Diagnostics Holdings fundamentals help investors to digest information that contributes to Integrated Diagnostics' financial success or failures. It also enables traders to predict the movement of Integrated Stock. The fundamental analysis module provides a way to measure Integrated Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Integrated Diagnostics stock.
At this time, Integrated Diagnostics' Minority Interest is comparatively stable compared to the past year. Tax Provision is likely to gain to about 339.1 M in 2024, whereas Selling And Marketing Expenses is likely to drop slightly above 92 M in 2024. Integrated | Select Account or Indicator |
Integrated Diagnostics Holdings Company Profit Margin Analysis
Integrated Diagnostics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Integrated Diagnostics Profit Margin | 0.17 % |
Most of Integrated Diagnostics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Integrated Diagnostics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Integrated Diagnostics Holdings has a Profit Margin of 0.1721%. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The profit margin for all United Kingdom stocks is notably lower than that of the firm.
Integrated Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Integrated Diagnostics's current stock value. Our valuation model uses many indicators to compare Integrated Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Integrated Diagnostics competition to find correlations between indicators driving Integrated Diagnostics's intrinsic value. More Info.Integrated Diagnostics Holdings is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Integrated Diagnostics Holdings is roughly 2.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Integrated Diagnostics' earnings, one of the primary drivers of an investment's value.Integrated Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Integrated Diagnostics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Integrated Diagnostics could also be used in its relative valuation, which is a method of valuing Integrated Diagnostics by comparing valuation metrics of similar companies.Integrated Diagnostics is currently under evaluation in profit margin category among its peers.
Integrated Fundamentals
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0969 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 232.12 M | ||||
| Shares Outstanding | 581.33 M | ||||
| Shares Owned By Insiders | 33.97 % | ||||
| Shares Owned By Institutions | 42.29 % | ||||
| Price To Book | 4.15 X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 4.12 B | ||||
| Gross Profit | 2.8 B | ||||
| EBITDA | 1.28 B | ||||
| Net Income | 737.36 M | ||||
| Total Debt | 1.18 B | ||||
| Book Value Per Share | 4.64 X | ||||
| Cash Flow From Operations | 543.66 M | ||||
| Earnings Per Share | 0.03 X | ||||
| Target Price | 27.67 | ||||
| Number Of Employees | 6.69 K | ||||
| Beta | 0.45 | ||||
| Market Capitalization | 23.25 B | ||||
| Total Asset | 5.77 B | ||||
| Retained Earnings | 1.33 B | ||||
| Working Capital | 686.94 M | ||||
| Net Asset | 5.77 B |
About Integrated Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Integrated Diagnostics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integrated Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integrated Diagnostics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 161.1 M | 150.6 M | |
| Total Revenue | 4.1 B | 2.3 B | |
| Cost Of Revenue | 2.6 B | 2.7 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.